3rd Annual Pharma Impurity Conclave 2025

​The 3rd Annual Pharma Impurity Conclave 2025, organized by Eminence Business Media, is scheduled for May 8–9, 2025, as a virtual training program. This event aims to address the persistent challenges of drug impurities in the pharmaceutical industry, with a particular focus on nitrosamines. Through in-depth exploration of impurity profiling practices, attendees will gain insights into evaluating sources and processes, and quantifying uncertainty in impurity mechanisms. The program includes practical case studies, the latest guideline updates, and interactive sessions designed to enhance understanding and application of impurity management strategies.

The conclave is tailored for professionals across various departments, including R&D, Analytical R&D, Quality, Regulatory, and Manufacturing teams. Participants will benefit from dedicated Q&A sessions, group exercises, and six months of continuous learning support. The event also offers networking opportunities with industry leaders and peers, fostering collaboration and knowledge exchange.

Event Highlights:

• Dates: May 8–9, 2025

• Format: Virtual Training Program

• Event Type: Conference

• Key Topics:

  • Impurity profiling and evaluation

  • Nitrosamine challenges and solutions

  • Regulatory guideline updates

  • Quantifying uncertainty in impurity mechanisms

• Featured Speakers from Big Pharma:

  • Shailesh Buha – Lead Analytical Development, Lotus Pharma

  • Dr. Manoj Kumar Singh – Senior Vice President, Micro Labs

  • Dr. BV Ravichandra – DGM & Head - Global Toxicology and Non Clinical Development, Amneal